2006-2008년 국내 임상검체 및 동물에서 분리된 Non-Typhoidal Salmonella 균주에서의 Extended-Spectrum β-Lactamase, Plasmid-Mediated AmpC β-Lactamase와 Plasmid-Mediated Quinolone 내성 qnr 유전자의 빈도 = A Korean Nationwide Surveillance Study for Non-Typhoidal Salmonella Isolated in Humans and Food Animals from 2006 to 2008: Extended-Spectrum β-Lactamase, Plasmid-Mediated AmpC β-Lactamase, and Plasmid-Mediated Quinolone Resistance qnr Genes

다국어 초록 (Multilingual Abstract)

Background: The emergence of non-typhoidal Salmonella (NTS) with decreased susceptibilities to fluoroquinolone, ampicillin, or ceftriaxone has been reported worldwide. However, current surveillance studies of resistance among NTS in Korea are limited. Thus, the antimicrobial susceptibilities; resistance mechanisms such as extended-spectrum β-lactamase (ESBL), plasmid-mediated AmpC β-lactamase (PABL), and plasmid-mediated quinolone resistance (PMQR); and molecular epidemiologic characteristics were investigated in the present study.
Methods: National Institute of Health and National Veterinary Research and Quarantine Service collected NTS strains from 219 clinical and 293 non-clinical specimens from 2006 to 2008. The antimicrobial susceptibilities were determined using the Clinical and Laboratory Standards Institute disk diffusion test. ESBL, PABL, and qnr genotyping were performed using PCR and nucleotide sequencing. Pulsed-field gelelectrophoresis was used for the molecular epidemiologic study.
Results: The resistance to ampicillin in clinical and non-clinical NTS was 49% and 18 to 47%, respectively. The resistance rates to trimethoprim-sulfamethoxazole in clinical and non-clinical NTS were 8% and 0 to 41%, respectively. The rates to extended- spectrum cephalosporin were 0 to 1%. One CTX-M- 15-producing isolate and four CMY-2-producing isolates were detected. Notably, PFGE analysis showed four isolates carrying blaCMY-2, including one non-clinical strain had high clonality. Although the rate of ciprofloxacin resistance was very low, two qnrS1-carrying NTS strains were detected in non-clinical specimens.
Conclusion: The resistance rates to ampicillin in both clinical and non-clinical NTS were high, while those to trimethoprim-sulfamethoxazole varied depending on the specimen. NTS strains harboring CTX-M-15-type ESBL or CMY-2-type PABL were detected even though the resistance rates to cephalosporins were very low. Four NTS strains carrying the blaCMY-2-gene implied zoonotic infection. Continuous effort to minimize transfer of resistance genes in NTS is necessary.

참고문헌 (Reference)

1 Robicsek A, "The worldwide emergence of plasmid-mediated quinolone resistance" 6 : 629-640, 2006

2 Lee HJ, "Salmonellosis" 4 : 5-10, 2001

3 Arlet G, "Salmonella resistant to extended-spectrum cephalosporins: prevalence and epidemiology" 8 : 1945-1954, 2006

4 Gay K, "Plasmid-mediated quinolone resistance in non-Typhi serotypes of Salmonella enterica" 43 : 297-304, 2006

5 Wang M, "Plasmid-mediated quinolone resistance in clinical isolates of Escherichia coli from Shanghai, China" 47 : 2242-2248, 2003

6 Sjölund-Karlsson M, "Plasmid-mediated quinolone resistance among non- Typhi Salmonella enterica isolates" 16 : 1789-1791, 2010

7 Drieux L, "Phenotypic detection of extended-spectrum beta-lactamase production in Enterobacteriaceae: review and bench guide" 14 (14): 90-103, 2008

8 Clinical and Laboratory Standards Institute, "Performance standards for antimicrobial susceptibility testing; nineteenth informational supplement" CLSI 2009

9 Centers for Disease Control and Prevention (CDC), "Outbreak of multidrug-resistant Salmonella Newport--United States, January- April 2002" 51 : 545-548, 2002

10 Yong D, "Nosocomial outbreak of pediatric gastroenteritis caused by CTX-M- 14-type extended-spectrum beta-lactamase-producing strains of Salmonella enterica serovar London" 43 : 3519-3521, 2005

11 Ran L, "Laboratory-based surveillance of nontyphoidal Salmonella infections in China" 8 : 921-927, 2011

12 Tenover FC, "Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing" 33 : 2233-2239, 1995

13 정진용, "Increasing incidence of quinolone resistance in human non-typhoid Salmonella enterica isolates in Korea and mechanisms involved in quinolone resistance" Oxford University Press 56 (56): 1111-1114, 200512

14 Al-Mashhadani M, "Foreign travel and decreased ciprofloxacin susceptibility in Salmonella enterica infections" 17 : 123-125, 2011

15 Antunes P, "First description of qnrS1-IncN plasmid in a ST11 Salmonella Enteritidis clinical isolate from Portugal" 69 : 463-465, 2011

16 Miriagou V, "Expandedspectrum cephalosporin resistance in non-typhoid Salmonella" 23 : 547-555, 2004

17 Crump JA, "Emerging Infections Program NARMS Working Group. Antimicrobial resistance among invasive nontyphoidal Salmonella enterica isolates in the United States: National Antimicrobial Resistance Monitoring System, 1996 to 2007" 55 : 1148-1154, 2011

18 Sjölund-Karlsson M, "Emergence of plasmid-mediated quinolone resistance among non-Typhi Salmonella enterica isolates from humans in the United States" 53 : 2142-2144, 2009

19 Tamang MD, "Emergence of extended-spectrum beta-lactamase (CTX-M-15 and CTX-M-14)-producing nontyphoid Salmonella with reduced susceptibility to ciprofloxacin among food animals and humans in Korea" 49 : 2671-2675, 2011

20 Lee K, "Diversity of TEM-52 extended-spectrum beta-lactamase-producing non-typhoidal Salmonella isolates in Korea" 52 : 493-496, 2003

21 Pérez-Pérez FJ, "Detection of plasmid-mediated AmpC beta-lactamase genes in clinical isolates by using multiplex PCR" 40 : 2153-2162, 2002

22 Song W, "Appearance of Salmonella enterica isolates producing plasmid-mediated AmpC beta-lactamase, CMY-2, in South Korea" 52 : 281-284, 2005

23 Esaki H, "Antimicrobial susceptibility of Salmonella isolated from cattle, swine and poultry (2001-2002): report from the Japanese Veterinary Antimicrobial Resistance Monitoring Program" 53 : 266-270, 2004

24 Parry CM, "Antimicrobial resistance in typhoidal and nontyphoidal salmonellae" 21 : 531-538, 2008